News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
775,229 Results
Type
Article (51775)
Company Profile (375)
Press Release (723062)
Multimedia
Podcasts (132)
Webinars (23)
Section
Business (215856)
Career Advice (2446)
Deals (37760)
Drug Delivery (138)
Drug Development (84127)
Employer Resources (181)
FDA (17555)
Job Trends (15817)
News (365081)
Policy (34939)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2855)
Academic (1)
Accelerated approval (43)
Adcomms (31)
Allergies (169)
Alliances (53571)
ALS (199)
Alzheimer's disease (1834)
Antibody-drug conjugate (ADC) (393)
Approvals (17838)
Artificial intelligence (685)
Autoimmune disease (234)
Automation (52)
Bankruptcy (382)
Best Places to Work (12089)
BIOSECURE Act (20)
Biosimilars (207)
Biotechnology (247)
Bladder cancer (181)
Brain cancer (70)
Breast cancer (707)
Cancer (5488)
Cardiovascular disease (474)
Career advice (2076)
Career pathing (43)
CAR-T (315)
CDC (62)
Celiac Disease (2)
Cell therapy (856)
Cervical cancer (42)
Clinical research (72052)
Collaboration (2019)
Company closure (5)
Compensation (1281)
Complete response letters (77)
COVID-19 (2910)
CRISPR (109)
C-suite (1023)
Cystic fibrosis (157)
Data (7166)
Decentralized trials (3)
Denatured (45)
Depression (164)
Dermatology (58)
Diabetes (561)
Diagnostics (7250)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (333)
Drug pricing (210)
Drug shortages (31)
Duchenne muscular dystrophy (279)
Earnings (93613)
Editorial (63)
Employer branding (22)
Employer resources (161)
Events (124709)
Executive appointments (1080)
FDA (21081)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1692)
Gene editing (230)
Generative AI (65)
Gene therapy (712)
GLP-1 (1099)
Government (4991)
Grass and pollen (7)
Guidances (399)
Healthcare (20051)
HIV (79)
Huntington's disease (54)
IgA nephropathy (94)
Immunology and inflammation (296)
Immuno-oncology (85)
Indications (158)
Infectious disease (3239)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (133)
Intellectual property (281)
Interviews (415)
IPO (17124)
IRA (53)
Job creations (4065)
Job search strategy (1719)
JPM (65)
Kidney cancer (18)
Labor market (93)
Layoffs (599)
Leadership (40)
Legal (8542)
Liver cancer (100)
Longevity (28)
Lung cancer (737)
Lymphoma (413)
Machine learning (54)
Management (65)
Manufacturing (966)
MASH (182)
Medical device (14771)
Medtech (14853)
Mergers & acquisitions (21828)
Metabolic disorders (1470)
mRNA (201)
Multiple sclerosis (175)
NASH (20)
Neurodegenerative disease (407)
Neuropsychiatric disorders (109)
Neuroscience (3288)
Neurotech (1)
NextGen: Class of 2026 (7074)
Non-profit (4790)
Now hiring (73)
Obesity (699)
Opinion (323)
Ovarian cancer (187)
Pain (233)
Pancreatic cancer (261)
Parkinson's disease (348)
Partnered (34)
Patents (571)
Patient recruitment (609)
Peanut (64)
People (62518)
Pharmaceutical (75)
Pharmacy benefit managers (34)
Phase 1 (22565)
Phase 2 (31636)
Phase 3 (23593)
Pipeline (7250)
Policy (325)
Postmarket research (2671)
Preclinical (9734)
Press Release (72)
Prostate cancer (284)
Psychedelics (55)
Radiopharmaceuticals (325)
Rare diseases (1052)
Real estate (6568)
Recruiting (71)
Regulatory (26494)
Reports (55)
Research institute (2631)
Resumes & cover letters (400)
Rett syndrome (32)
RNA editing (21)
RSV (88)
Schizophrenia (172)
Series A (285)
Series B (208)
Service/supplier (15)
Sickle cell disease (110)
Special edition (24)
Spinal muscular atrophy (170)
Sponsored (49)
Startups (3990)
State (2)
Stomach cancer (19)
Supply chain (121)
Tariffs (87)
The Weekly (84)
Vaccines (1152)
Venture capital (106)
Weight loss (457)
Women's health (112)
Worklife (21)
Date
Today (155)
Last 7 days (730)
Last 30 days (2839)
Last 365 days (31449)
2026 (8294)
2025 (31828)
2024 (36774)
2023 (41603)
2022 (52861)
2021 (57497)
2020 (56269)
2019 (49251)
2018 (37218)
2017 (34325)
2016 (34124)
2015 (40238)
2014 (33962)
2013 (29306)
2012 (31437)
2011 (32002)
2010 (30054)
Location
Africa (853)
Alabama (93)
Alaska (7)
Arizona (349)
Arkansas (15)
Asia (44003)
Australia (7313)
California (12538)
Canada (3547)
China (1279)
Colorado (534)
Connecticut (538)
Delaware (380)
Europe (96945)
Florida (1869)
Georgia (411)
Hawaii (3)
Idaho (67)
Illinois (997)
India (81)
Indiana (573)
Iowa (23)
Japan (499)
Kansas (134)
Kentucky (48)
Louisiana (40)
Maine (73)
Maryland (1516)
Massachusetts (9090)
Michigan (376)
Minnesota (700)
Mississippi (7)
Missouri (150)
Montana (36)
Nebraska (29)
Nevada (140)
New Hampshire (89)
New Jersey (3339)
New Mexico (31)
New York (3310)
North Carolina (1628)
North Dakota (10)
Northern California (6154)
Ohio (380)
Oklahoma (24)
Oregon (45)
Pennsylvania (2524)
Puerto Rico (27)
Rhode Island (51)
South America (1255)
South Carolina (77)
South Dakota (1)
Southern California (4933)
Tennessee (203)
Texas (1987)
United States (44681)
Utah (378)
Vermont (1)
Virginia (300)
Washington D.C. (83)
Washington State (1016)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
775,229 Results for "image technology laboratories inc acquired by clear arts inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SkinCure Oncology Introduces FDA-Cleared GentleBeam™, Expanding Image-Guided Capabilities in Dermatology Practices
March 24, 2026
·
2 min read
Press Releases
VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.
March 10, 2026
·
6 min read
Press Releases
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
March 9, 2026
·
9 min read
Press Releases
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI
December 15, 2025
·
8 min read
Press Releases
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
December 18, 2025
·
4 min read
Press Releases
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
March 27, 2026
·
6 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Quanta System Inc.: Strengthening the U.S. Presence of Italian Laser Technology
March 1, 2026
·
4 min read
Complete response letters
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.
March 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
March 25, 2026
·
13 min read
1 of 77,523
Next
